Therapeutic Nuclear Medicine Market size is expected to reach US$ 6.74 Bn. by 2029, at a CAGR of 4.7% during the forecast period. The report study has analyzed the revenue impact of COVID 19 pandemic on the sales revenue of market leaders, market followers, and market disrupters in the report, and the same is reflected in our analysis.To know about the Research Methodology :- Request Free Sample Report Nuclear medicines or radiopharmaceuticals are regular medications that are utilized for the diagnosis of dysfunctions in human body tissue. Nuclear medicines are utilized for both diagnostic and remedial purposes and there are 30+ explicit radiopharmaceuticals utilized by medical specialists. Different types of nuclear medicines are valuable in treating cancer, neurological issues, gastrointestinal, and different diseases. Growing rate of disease is one of the main factors expected to boost the market for nuclear medicine. For example, as indicated by WHO, in 2019, around the world there were an expected 9.6 million deaths because of cancer. Moreover, the expanding prevalence of cardiovascular diseases is adding to the growth of the nuclear medicine market. Cancer causes nearly one out of six deaths over the world and the population experiencing different type of it is expanding continuously because of lifestyle changes involving tobacco and liquor, low intake of leafy foods, and absence of physical activity. Advances in radiotracers, approach of alpha radio immunotherapy based focused on cancer treatments, and ventures by means of public and private partnerships to change symptomatic measures are some of different components expected to drive the interest in radiopharmaceuticals near future. On the other hand, significantly shorter half-existence of radiopharmaceuticals, generously significant expense of these specific medicines are some of the restraints impeding the market from achieving more prominent benefit. North America dominated the general market as far as income in 2019 because of high interests in R&D and backing of government towards the utilization of medical isotopes which are driving the market. Likewise, the large share can be ascribed to the advancement of novel technologies for radioisotope production, government funding, and company initiatives in the region. The Europe market additionally held a large share in the global market in 2019. The market in Asia Pacific is projected to grow significantly during the forecast period. Rising geriatric population and awareness about nuclear medicines and molecular imaging are adding to the growth of the radiopharmaceuticals market in this region. Besides, this region is focusing in on the improvement of radiopharmaceuticals for the diagnosis and treatment of different diseases. The objective of the report is to present a comprehensive analysis of the Therapeutic Nuclear Medicine Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Therapeutic Nuclear Medicine Market dynamics, structure by analyzing the market segments and projects the Therapeutic Nuclear Medicine Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Therapeutic Nuclear Medicine Market make the report investor’s guide.
Scope of the Therapeutic Nuclear Medicine Market: Inquire before buying
Global Therapeutic Nuclear Medicine Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 4.88 Bn. Forecast Period 2023 to 2029 CAGR: 4.7% Market Size in 2029: US $ 6.74 Bn. Segments Covered: by Type Diagnostic Nuclear Medicine Therapeutic Nuclear Medicine Brachytherapy Isotopes by Application SPECT Applications PET Applications Therapeutic Applications by Procedural Volume Assessment Diagnostic Procedures Therapeutic Procedures Therapeutic Nuclear Medicine Market, By Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Key players operating in Therapeutic Nuclear Medicine Market
1. Cardinal Health 2. GE Healthcare 3. Curium 4. Lantheus Medical Imaging 5. Bayer AG 6. Bracco Imaging 7. Eczacýbaþý-Monrol Nuclear Products (Turkey) 8. Nordion (Canada) 9. Advanced Accelerator Applications (France) 10.NTP Radioisotopes (South Africa) 11.JSC Isotope (Russia) 12.NorthStar Medical Radioisotopes (US) 13.Eckert & Ziegler (Germany) 14.Jubilant DraxImage (Canada) 15.PharmaLogic (US) 16.Institute of Isotopes Co., Ltd. (Hungary) 17.Sinotau Pharmaceuticals (China) 18.Isotopia Molecular Imaging Limited (Israel) 19.SHINE Medical Technologies (US) 20.Global Medical Solutions (US) Frequently Asked Questions: 1] What segments are covered in the Global Therapeutic Nuclear Medicine Market report? Ans. The segments covered in the Market report are based on Application, Type, and Procedural Volume. 2] Which region is expected to hold the highest share in the Global Market? Ans. The North American region is expected to hold the highest share in Market. 3] What is the market size of the Global Market by 2029? Ans. The market size of the Global Market by 2029 is expected to reach US$ 6.74 Bn. 4] What is the forecast period for the Global Market? Ans. The forecast period for the Market is 2023-2029. 5] What was the market size of the Global Market in 2022? Ans. The market size of the Global Market in 2022 was valued at US$ 4.88 Bn.
Therapeutic Nuclear Medicine Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Therapeutic Nuclear Medicine Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Therapeutic Nuclear Medicine Market Analysis and Forecast 6.1. Therapeutic Nuclear Medicine Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Therapeutic Nuclear Medicine Market Analysis and Forecast, By Type 7.1. Introduction and Definition 7.2. Key Findings 7.3. Therapeutic Nuclear Medicine Market Value Share Analysis, By Type 7.4. Therapeutic Nuclear Medicine Market Size (US$ Bn) Forecast, By Type 7.5. Therapeutic Nuclear Medicine Market Analysis, By Type 7.6. Therapeutic Nuclear Medicine Market Attractiveness Analysis, By Type 8. Therapeutic Nuclear Medicine Market Analysis and Forecast, By Procedural Volume Assessment 8.1. Introduction and Definition 8.2. Key Findings 8.3. Therapeutic Nuclear Medicine Market Value Share Analysis, By Procedural Volume Assessment 8.4. Therapeutic Nuclear Medicine Market Size (US$ Bn) Forecast, By Procedural Volume Assessment 8.5. Therapeutic Nuclear Medicine Market Analysis, By Procedural Volume Assessment 8.6. Therapeutic Nuclear Medicine Market Attractiveness Analysis, By Procedural Volume Assessment 9. Therapeutic Nuclear Medicine Market Analysis and Forecast, By Application 9.1. Introduction and Definition 9.2. Key Findings 9.3. Therapeutic Nuclear Medicine Market Value Share Analysis, By Application 9.4. Therapeutic Nuclear Medicine Market Size (US$ Bn) Forecast, By Application 9.5. Therapeutic Nuclear Medicine Market Analysis, By Application 9.6. Therapeutic Nuclear Medicine Market Attractiveness Analysis, By Application 10. Therapeutic Nuclear Medicine Market Analysis, by Region 10.1. Therapeutic Nuclear Medicine Market Value Share Analysis, by Region 10.2. Therapeutic Nuclear Medicine Market Size (US$ Bn) Forecast, by Region 11. North America Therapeutic Nuclear Medicine Market Analysis 11.1. Key Findings 11.2. North America Therapeutic Nuclear Medicine Market Overview 11.3. North America Therapeutic Nuclear Medicine Market Value Share Analysis, By Type 11.4. North America Therapeutic Nuclear Medicine Market Forecast, By Type 11.4.1. Diagnostic Nuclear Medicine 11.4.2. Therapeutic Nuclear Medicine 11.4.3. Brachytherapy Isotopes 11.5. North America Therapeutic Nuclear Medicine Market Value Share Analysis, By Procedural Volume Assessment 11.6. North America Therapeutic Nuclear Medicine Market Forecast, By Procedural Volume Assessment 11.6.1. Diagnostic Procedures 11.6.2. Therapeutic Procedures 11.7. North America Therapeutic Nuclear Medicine Market Value Share Analysis, By Application 11.8. North America Therapeutic Nuclear Medicine Market Forecast, By Application 11.8.1. SPECT Applications 11.8.2. PET Applications 11.8.3. Therapeutic Applications 11.9. North America Therapeutic Nuclear Medicine Market Value Share Analysis, by Country 11.9.1. U.S. 11.9.2. Canada 11.10. U.S. Therapeutic Nuclear Medicine Market Value Share Analysis, By Type 11.11. U.S. Therapeutic Nuclear Medicine Market Forecast, By Type 11.11.1. Diagnostic Nuclear Medicine 11.11.2. Therapeutic Nuclear Medicine 11.11.3. Brachytherapy Isotopes 11.12. U.S. Therapeutic Nuclear Medicine Market Value Share Analysis, By Procedural Volume Assessment 11.13. U.S. Therapeutic Nuclear Medicine Market Forecast, By Procedural Volume Assessment 11.13.1. Diagnostic Procedures 11.13.2. Therapeutic Procedures 11.14. U.S. Therapeutic Nuclear Medicine Market Value Share Analysis, By Application 11.15. U.S. Therapeutic Nuclear Medicine Market Forecast, By Application 11.15.1. SPECT Applications 11.15.2. PET Applications 11.15.3. Therapeutic Applications 11.16. Canada Therapeutic Nuclear Medicine Market Value Share Analysis, By Type 11.17. Canada Therapeutic Nuclear Medicine Market Forecast, By Type 11.17.1. Diagnostic Nuclear Medicine 11.17.2. Therapeutic Nuclear Medicine 11.17.3. Brachytherapy Isotopes 11.18. Canada Therapeutic Nuclear Medicine Market Value Share Analysis, By Procedural Volume Assessment 11.19. Canada Therapeutic Nuclear Medicine Market Forecast, By Procedural Volume Assessment 11.19.1. Diagnostic Procedures 11.19.2. Therapeutic Procedures 11.20. Canada Therapeutic Nuclear Medicine Market Value Share Analysis, By Application 11.21. Canada Therapeutic Nuclear Medicine Market Forecast, By Application 11.21.1. SPECT Applications 11.21.2. PET Applications 11.21.3. Therapeutic Applications 11.22. PEST Analysis 11.23. Key Trends 11.24. Key Developments 12. Europe Therapeutic Nuclear Medicine Market Analysis 12.1. Key Findings 12.2. Europe Therapeutic Nuclear Medicine Market Overview 12.3. Europe Therapeutic Nuclear Medicine Market Value Share Analysis, By Type 12.4. Europe Therapeutic Nuclear Medicine Market Forecast, By Type 12.4.1. Diagnostic Nuclear Medicine 12.4.2. Therapeutic Nuclear Medicine 12.4.3. Brachytherapy Isotopes 12.5. Europe Therapeutic Nuclear Medicine Market Value Share Analysis, By Procedural Volume Assessment 12.6. Europe Therapeutic Nuclear Medicine Market Forecast, By Procedural Volume Assessment 12.6.1. Diagnostic Procedures 12.6.2. Therapeutic Procedures 12.7. Europe Therapeutic Nuclear Medicine Market Value Share Analysis, By Application 12.8. Europe Therapeutic Nuclear Medicine Market Forecast, By Application 12.8.1. SPECT Applications 12.8.2. PET Applications 12.8.3. Therapeutic Applications 12.9. Europe Therapeutic Nuclear Medicine Market Value Share Analysis, by Country 12.9.1. U.K. 12.9.2. Germany 12.9.3. France 12.9.4. Italy 12.9.5. Spain 12.9.6. Rest of Europe 12.10. U.K. Therapeutic Nuclear Medicine Market Value Share Analysis, By Type 12.11. U.K. Therapeutic Nuclear Medicine Market Forecast, By Type 12.11.1. Diagnostic Nuclear Medicine 12.11.2. Therapeutic Nuclear Medicine 12.11.3. Brachytherapy Isotopes 12.12. U.K. Therapeutic Nuclear Medicine Market Value Share Analysis, By Procedural Volume Assessment 12.13. U.K. Therapeutic Nuclear Medicine Market Forecast, By Procedural Volume Assessment 12.13.1. Diagnostic Procedures 12.13.2. Therapeutic Procedures 12.14. U.K. Therapeutic Nuclear Medicine Market Value Share Analysis, By Application 12.15. U.K. Therapeutic Nuclear Medicine Market Forecast, By Application 12.15.1. SPECT Applications 12.15.2. PET Applications 12.15.3. Therapeutic Applications 12.16. Germany Therapeutic Nuclear Medicine Market Value Share Analysis, By Type 12.17. Germany Therapeutic Nuclear Medicine Market Forecast, By Type 12.17.1. Diagnostic Nuclear Medicine 12.17.2. Therapeutic Nuclear Medicine 12.17.3. Brachytherapy Isotopes 12.18. Germany Therapeutic Nuclear Medicine Market Value Share Analysis, By Procedural Volume Assessment 12.19. Germany Therapeutic Nuclear Medicine Market Forecast, By Procedural Volume Assessment 12.19.1. Diagnostic Procedures 12.19.2. Therapeutic Procedures 12.20. Germany Therapeutic Nuclear Medicine Market Value Share Analysis, By Application 12.21. Germany Therapeutic Nuclear Medicine Market Forecast, By Application 12.21.1. SPECT Applications 12.21.2. PET Applications 12.21.3. Therapeutic Applications 12.22. France Therapeutic Nuclear Medicine Market Value Share Analysis, By Type 12.23. France Therapeutic Nuclear Medicine Market Forecast, By Type 12.23.1. Diagnostic Nuclear Medicine 12.23.2. Therapeutic Nuclear Medicine 12.23.3. Brachytherapy Isotopes 12.24. France Therapeutic Nuclear Medicine Market Value Share Analysis, By Procedural Volume Assessment 12.25. France Therapeutic Nuclear Medicine Market Forecast, By Procedural Volume Assessment 12.25.1. Diagnostic Procedures 12.25.2. Therapeutic Procedures 12.26. France Therapeutic Nuclear Medicine Market Value Share Analysis, By Application 12.27. France Therapeutic Nuclear Medicine Market Forecast, By Application 12.27.1. SPECT Applications 12.27.2. PET Applications 12.27.3. Therapeutic Applications 12.28. Italy Therapeutic Nuclear Medicine Market Value Share Analysis, By Type 12.29. Italy Therapeutic Nuclear Medicine Market Forecast, By Type 12.29.1. Diagnostic Nuclear Medicine 12.29.2. Therapeutic Nuclear Medicine 12.29.3. Brachytherapy Isotopes 12.30. Italy Therapeutic Nuclear Medicine Market Value Share Analysis, By Procedural Volume Assessment 12.31. Italy Therapeutic Nuclear Medicine Market Forecast, By Procedural Volume Assessment 12.31.1. Diagnostic Procedures 12.31.2. Therapeutic Procedures 12.32. Italy Therapeutic Nuclear Medicine Market Value Share Analysis, By Application 12.33. Italy Therapeutic Nuclear Medicine Market Forecast, By Application 12.33.1. SPECT Applications 12.33.2. PET Applications 12.33.3. Therapeutic Applications 12.34. Spain Therapeutic Nuclear Medicine Market Value Share Analysis, By Type 12.35. Spain Therapeutic Nuclear Medicine Market Forecast, By Type 12.35.1. Diagnostic Nuclear Medicine 12.35.2. Therapeutic Nuclear Medicine 12.35.3. Brachytherapy Isotopes 12.36. Spain Therapeutic Nuclear Medicine Market Value Share Analysis, By Procedural Volume Assessment 12.37. Spain Therapeutic Nuclear Medicine Market Forecast, By Procedural Volume Assessment 12.37.1. Diagnostic Procedures 12.37.2. Therapeutic Procedures 12.38. Spain Therapeutic Nuclear Medicine Market Value Share Analysis, By Application 12.39. Spain Therapeutic Nuclear Medicine Market Forecast, By Application 12.39.1. SPECT Applications 12.39.2. PET Applications 12.39.3. Therapeutic Applications 12.40. Rest of Europe Therapeutic Nuclear Medicine Market Value Share Analysis, By Type 12.41. Rest of Europe Therapeutic Nuclear Medicine Market Forecast, By Type 12.41.1. Diagnostic Nuclear Medicine 12.41.2. Therapeutic Nuclear Medicine 12.41.3. Brachytherapy Isotopes 12.42. Rest of Europe Therapeutic Nuclear Medicine Market Value Share Analysis, By Procedural Volume Assessment 12.43. Rest of Europe Therapeutic Nuclear Medicine Market Forecast, By Procedural Volume Assessment 12.43.1. Diagnostic Procedures 12.43.2. Therapeutic Procedures 12.44. Rest of Europe Therapeutic Nuclear Medicine Market Value Share Analysis, By Application 12.45. Rest of Europe Therapeutic Nuclear Medicine Market Forecast, By Application 12.45.1. SPECT Applications 12.45.2. PET Applications 12.45.3. Therapeutic Applications 12.46. PEST Analysis 12.47. Key Trends 12.48. Key Developments 13. Asia Pacific Therapeutic Nuclear Medicine Market Analysis 13.1. Key Findings 13.2. Asia Pacific Therapeutic Nuclear Medicine Market Overview 13.3. Asia Pacific Therapeutic Nuclear Medicine Market Value Share Analysis, By Type 13.4. Asia Pacific Therapeutic Nuclear Medicine Market Forecast, By Type 13.4.1. Diagnostic Nuclear Medicine 13.4.2. Therapeutic Nuclear Medicine 13.4.3. Brachytherapy Isotopes 13.5. Asia Pacific Therapeutic Nuclear Medicine Market Value Share Analysis, By Procedural Volume Assessment 13.6. Asia Pacific Therapeutic Nuclear Medicine Market Forecast, By Procedural Volume Assessment 13.6.1. Diagnostic Procedures 13.6.2. Therapeutic Procedures 13.7. Asia Pacific Therapeutic Nuclear Medicine Market Value Share Analysis, By Application 13.8. Asia Pacific Therapeutic Nuclear Medicine Market Forecast, By Application 13.8.1. SPECT Applications 13.8.2. PET Applications 13.8.3. Therapeutic Applications 13.9. Asia Pacific Therapeutic Nuclear Medicine Market Value Share Analysis, by Country 13.9.1. China 13.9.2. India 13.9.3. Japan 13.9.4. ASEAN 13.9.5. Rest of Asia Pacific 13.10. China Therapeutic Nuclear Medicine Market Value Share Analysis, By Type 13.11. China Therapeutic Nuclear Medicine Market Forecast, By Type 13.11.1. Diagnostic Nuclear Medicine 13.11.2. Therapeutic Nuclear Medicine 13.11.3. Brachytherapy Isotopes 13.12. China Therapeutic Nuclear Medicine Market Value Share Analysis, By Procedural Volume Assessment 13.13. China Therapeutic Nuclear Medicine Market Forecast, By Procedural Volume Assessment 13.13.1. Diagnostic Procedures 13.13.2. Therapeutic Procedures 13.14. China Therapeutic Nuclear Medicine Market Value Share Analysis, By Application 13.15. China Therapeutic Nuclear Medicine Market Forecast, By Application 13.15.1. SPECT Applications 13.15.2. PET Applications 13.15.3. Therapeutic Applications 13.16. India Therapeutic Nuclear Medicine Market Value Share Analysis, By Type 13.17. India Therapeutic Nuclear Medicine Market Forecast, By Type 13.17.1. Diagnostic Nuclear Medicine 13.17.2. Therapeutic Nuclear Medicine 13.17.3. Brachytherapy Isotopes 13.18. India Therapeutic Nuclear Medicine Market Value Share Analysis, By Procedural Volume Assessment 13.19. India Therapeutic Nuclear Medicine Market Forecast, By Procedural Volume Assessment 13.19.1. Diagnostic Procedures 13.19.2. Therapeutic Procedures 13.20. India Therapeutic Nuclear Medicine Market Value Share Analysis, By Application 13.21. India Therapeutic Nuclear Medicine Market Forecast, By Application 13.21.1. SPECT Applications 13.21.2. PET Applications 13.21.3. Therapeutic Applications 13.22. Japan Therapeutic Nuclear Medicine Market Value Share Analysis, By Type 13.23. Japan Therapeutic Nuclear Medicine Market Forecast, By Type 13.23.1. Diagnostic Nuclear Medicine 13.23.2. Therapeutic Nuclear Medicine 13.23.3. Brachytherapy Isotopes 13.24. Japan Therapeutic Nuclear Medicine Market Value Share Analysis, By Procedural Volume Assessment 13.25. Japan Therapeutic Nuclear Medicine Market Forecast, By Procedural Volume Assessment 13.25.1. Diagnostic Procedures 13.25.2. Therapeutic Procedures 13.26. Japan Therapeutic Nuclear Medicine Market Value Share Analysis, By Application 13.27. Japan Therapeutic Nuclear Medicine Market Forecast, By Application 13.27.1. SPECT Applications 13.27.2. PET Applications 13.27.3. Therapeutic Applications 13.28. ASEAN Therapeutic Nuclear Medicine Market Value Share Analysis, By Type 13.29. ASEAN Therapeutic Nuclear Medicine Market Forecast, By Type 13.29.1. Diagnostic Nuclear Medicine 13.29.2. Therapeutic Nuclear Medicine 13.29.3. Brachytherapy Isotopes 13.30. ASEAN Therapeutic Nuclear Medicine Market Value Share Analysis, By Procedural Volume Assessment 13.31. ASEAN Therapeutic Nuclear Medicine Market Forecast, By Procedural Volume Assessment 13.31.1. Diagnostic Procedures 13.31.2. Therapeutic Procedures 13.32. ASEAN Therapeutic Nuclear Medicine Market Value Share Analysis, By Application 13.33. ASEAN Therapeutic Nuclear Medicine Market Forecast, By Application 13.33.1. SPECT Applications 13.33.2. PET Applications 13.33.3. Therapeutic Applications 13.34. Rest of Asia Pacific Therapeutic Nuclear Medicine Market Value Share Analysis, By Type 13.35. Rest of Asia Pacific Therapeutic Nuclear Medicine Market Forecast, By Type 13.35.1. Diagnostic Nuclear Medicine 13.35.2. Therapeutic Nuclear Medicine 13.35.3. Brachytherapy Isotopes 13.36. Rest of Asia Pacific Therapeutic Nuclear Medicine Market Value Share Analysis, By Procedural Volume Assessment 13.37. Rest of Asia Pacific Therapeutic Nuclear Medicine Market Forecast, By Procedural Volume Assessment 13.37.1. Diagnostic Procedures 13.37.2. Therapeutic Procedures 13.38. Rest of Asia Pacific Therapeutic Nuclear Medicine Market Value Share Analysis, By Application 13.39. Rest of Asia Pacific Therapeutic Nuclear Medicine Market Forecast, By Application 13.39.1. SPECT Applications 13.39.2. PET Applications 13.39.3. Therapeutic Applications 13.40. PEST Analysis 13.41. Key Trends 13.42. Key Developments 14. Middle East and Africa Therapeutic Nuclear Medicine Market Analysis 14.1. Key Findings 14.2. Middle East and Africa Therapeutic Nuclear Medicine Market Overview 14.3. Middle East and Africa Therapeutic Nuclear Medicine Market Value Share Analysis, By Type 14.4. Middle East and Africa Therapeutic Nuclear Medicine Market Forecast, By Type 14.4.1. Diagnostic Nuclear Medicine 14.4.2. Therapeutic Nuclear Medicine 14.4.3. Brachytherapy Isotopes 14.5. Middle East and Africa Therapeutic Nuclear Medicine Market Value Share Analysis, By Procedural Volume Assessment 14.6. Middle East and Africa Therapeutic Nuclear Medicine Market Forecast, By Procedural Volume Assessment 14.6.1. Diagnostic Procedures 14.6.2. Therapeutic Procedures 14.7. Middle East and Africa Therapeutic Nuclear Medicine Market Value Share Analysis, By Application 14.8. Middle East and Africa Therapeutic Nuclear Medicine Market Forecast, By Application 14.8.1. SPECT Applications 14.8.2. PET Applications 14.8.3. Therapeutic Applications 14.9. Middle East and Africa Therapeutic Nuclear Medicine Market Value Share Analysis, by Country 14.9.1. GCC 14.9.2. South Africa 14.9.3. Rest of Middle East and Africa 14.10. GCC Therapeutic Nuclear Medicine Market Value Share Analysis, By Type 14.11. GCC Therapeutic Nuclear Medicine Market Forecast, By Type 14.11.1. Diagnostic Nuclear Medicine 14.11.2. Therapeutic Nuclear Medicine 14.11.3. Brachytherapy Isotopes 14.12. GCC Therapeutic Nuclear Medicine Market Value Share Analysis, By Procedural Volume Assessment 14.13. GCC Therapeutic Nuclear Medicine Market Forecast, By Procedural Volume Assessment 14.13.1. Diagnostic Procedures 14.13.2. Therapeutic Procedures 14.14. GCC Therapeutic Nuclear Medicine Market Value Share Analysis, By Application 14.15. GCC Therapeutic Nuclear Medicine Market Forecast, By Application 14.15.1. SPECT Applications 14.15.2. PET Applications 14.15.3. Therapeutic Applications 14.16. South Africa Therapeutic Nuclear Medicine Market Value Share Analysis, By Type 14.17. South Africa Therapeutic Nuclear Medicine Market Forecast, By Type 14.17.1. Diagnostic Nuclear Medicine 14.17.2. Therapeutic Nuclear Medicine 14.17.3. Brachytherapy Isotopes 14.18. South Africa Therapeutic Nuclear Medicine Market Value Share Analysis, By Procedural Volume Assessment 14.19. South Africa Therapeutic Nuclear Medicine Market Forecast, By Procedural Volume Assessment 14.19.1. Diagnostic Procedures 14.19.2. Therapeutic Procedures 14.20. South Africa Therapeutic Nuclear Medicine Market Value Share Analysis, By Application 14.21. South Africa Therapeutic Nuclear Medicine Market Forecast, By Application 14.21.1. SPECT Applications 14.21.2. PET Applications 14.21.3. Therapeutic Applications 14.22. Rest of Middle East and Africa Therapeutic Nuclear Medicine Market Value Share Analysis, By Type 14.23. Rest of Middle East and Africa Therapeutic Nuclear Medicine Market Forecast, By Type 14.23.1. Diagnostic Nuclear Medicine 14.23.2. Therapeutic Nuclear Medicine 14.23.3. Brachytherapy Isotopes 14.24. Rest of Middle East and Africa Therapeutic Nuclear Medicine Market Value Share Analysis, By Procedural Volume Assessment 14.25. Rest of Middle East and Africa Therapeutic Nuclear Medicine Market Forecast, By Procedural Volume Assessment 14.25.1. Diagnostic Procedures 14.25.2. Therapeutic Procedures 14.26. Rest of Middle East and Africa Therapeutic Nuclear Medicine Market Value Share Analysis, By Application 14.27. Rest of Middle East and Africa Therapeutic Nuclear Medicine Market Forecast, By Application 14.27.1. SPECT Applications 14.27.2. PET Applications 14.27.3. Therapeutic Applications 14.28. PEST Analysis 14.29. Key Trends 14.30. Key Developments 15. South America Therapeutic Nuclear Medicine Market Analysis 15.1. Key Findings 15.2. South America Therapeutic Nuclear Medicine Market Overview 15.3. South America Therapeutic Nuclear Medicine Market Value Share Analysis, By Type 15.4. South America Therapeutic Nuclear Medicine Market Forecast, By Type 15.4.1. Diagnostic Nuclear Medicine 15.4.2. Therapeutic Nuclear Medicine 15.4.3. Brachytherapy Isotopes 15.5. South America Therapeutic Nuclear Medicine Market Value Share Analysis, By Procedural Volume Assessment 15.6. South America Therapeutic Nuclear Medicine Market Forecast, By Procedural Volume Assessment 15.6.1. Diagnostic Procedures 15.6.2. Therapeutic Procedures 15.7. South America Therapeutic Nuclear Medicine Market Value Share Analysis, By Application 15.8. South America Therapeutic Nuclear Medicine Market Forecast, By Application 15.8.1. SPECT Applications 15.8.2. PET Applications 15.8.3. Therapeutic Applications 15.9. South America Therapeutic Nuclear Medicine Market Value Share Analysis, by Country 15.9.1. Brazil 15.9.2. Mexico 15.9.3. Rest of South America 15.10. Brazil Therapeutic Nuclear Medicine Market Value Share Analysis, By Type 15.11. Brazil Therapeutic Nuclear Medicine Market Forecast, By Type 15.11.1. Diagnostic Nuclear Medicine 15.11.2. Therapeutic Nuclear Medicine 15.11.3. Brachytherapy Isotopes 15.12. Brazil Therapeutic Nuclear Medicine Market Value Share Analysis, By Procedural Volume Assessment 15.13. Brazil Therapeutic Nuclear Medicine Market Forecast, By Procedural Volume Assessment 15.13.1. Diagnostic Procedures 15.13.2. Therapeutic Procedures 15.14. Brazil Therapeutic Nuclear Medicine Market Value Share Analysis, By Application 15.15. Brazil Therapeutic Nuclear Medicine Market Forecast, By Application 15.15.1. SPECT Applications 15.15.2. PET Applications 15.15.3. Therapeutic Applications 15.16. Mexico Therapeutic Nuclear Medicine Market Value Share Analysis, By Type 15.17. Mexico Therapeutic Nuclear Medicine Market Forecast, By Type 15.17.1. Diagnostic Nuclear Medicine 15.17.2. Therapeutic Nuclear Medicine 15.17.3. Brachytherapy Isotopes 15.18. Mexico Therapeutic Nuclear Medicine Market Value Share Analysis, By Procedural Volume Assessment 15.19. Mexico Therapeutic Nuclear Medicine Market Forecast, By Procedural Volume Assessment 15.19.1. Diagnostic Procedures 15.19.2. Therapeutic Procedures 15.20. Mexico Therapeutic Nuclear Medicine Market Value Share Analysis, By Application 15.21. Mexico Therapeutic Nuclear Medicine Market Forecast, By Application 15.21.1. SPECT Applications 15.21.2. PET Applications 15.21.3. Therapeutic Applications 15.22. Rest of South America Therapeutic Nuclear Medicine Market Value Share Analysis, By Type 15.23. Rest of South America Therapeutic Nuclear Medicine Market Forecast, By Type 15.23.1. Diagnostic Nuclear Medicine 15.23.2. Therapeutic Nuclear Medicine 15.23.3. Brachytherapy Isotopes 15.24. Rest of South America Therapeutic Nuclear Medicine Market Value Share Analysis, By Procedural Volume Assessment 15.25. Rest of South America Therapeutic Nuclear Medicine Market Forecast, By Procedural Volume Assessment 15.25.1. Diagnostic Procedures 15.25.2. Therapeutic Procedures 15.26. Rest of South America Therapeutic Nuclear Medicine Market Value Share Analysis, By Application 15.27. Rest of South America Therapeutic Nuclear Medicine Market Forecast, By Application 15.27.1. SPECT Applications 15.27.2. PET Applications 15.27.3. Therapeutic Applications 15.28. PEST Analysis 15.29. Key Trends 15.30. Key Developments 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Cardinal Health 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Product Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Development Footprint 16.3.2. GE Healthcare 16.3.3. Curium 16.3.4. Lantheus Medical Imaging 16.3.5. Bayer AG 16.3.6. Bracco Imaging 16.3.7. Eczacýbaþý-Monrol Nuclear Products (Turkey) 16.3.8. Nordion (Canada) 16.3.9. Advanced Accelerator Applications (France) 16.3.10. NTP Radioisotopes (South Africa) 16.3.11. JSC Isotope (Russia) 16.3.12. NorthStar Medical Radioisotopes (US) 16.3.13. Eckert & Ziegler (Germany) 16.3.14. Jubilant DraxImage (Canada) 16.3.15. PharmaLogic (US) 16.3.16. Institute of Isotopes Co., Ltd. (Hungary) 16.3.17. Sinotau Pharmaceuticals (China) 16.3.18. Isotopia Molecular Imaging Limited (Israel) 16.3.19. SHINE Medical Technologies (US) 16.3.20. Global Medical Solutions (US)